Mirae Asset Global Investments Co., Ltd. Natera, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Natera, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 94,570 shares of NTRA stock, worth $15.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
94,570
Previous 94,936
0.39%
Holding current value
$15.8 Million
Previous $10.3 Million
16.92%
% of portfolio
0.05%
Previous 0.05%
Shares
21 transactions
Others Institutions Holding NTRA
# of Institutions
526Shares Held
119MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.91 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.13 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$775 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$762 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$671 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.2B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...